Key Market Indicators
Norwegian antihypertensive medicine sales are set to reach $12 million by 2026. In 2021, the country's sales stood at $12 million, a 0.4% increase on average year-on-year since 2007. Norway ranked 15th in 2021, with Ireland overtaking it with $12 million. Italy, Spain, and Australia held the 2nd, 3rd and 4th positions, respectively.
